A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1994

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Pentamidine isethionate

DRUG

Sulfamethoxazole-Trimethoprim

DRUG

Dapsone

DRUG

Zidovudine

Trial Locations (21)

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

21287

Johns Hopkins Adult AIDS CRS, Baltimore

33136

Univ. of Miami AIDS CRS, Miami

43210

The Ohio State Univ. AIDS CRS, Columbus

44106

Case CRS, Cleveland

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

55455

University of Minnesota, ACTU, Minneapolis

60614

Chicago Children's CRS, Chicago

90033

USC CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

94609

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland

98105

University of Washington AIDS CRS, Seattle

02114

Massachusetts General Hospital ACTG CRS, Boston

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Unknown

Washington U CRS, St Louis

Univ. of Rochester ACTG CRS, Rochester

Unc Aids Crs, Chapel Hill

Duke Univ. Med. Ctr. Adult CRS, Durham

Pitt CRS, Pittsburgh

Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000991 - A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients | Biotech Hunter | Biotech Hunter